![]() Vlassis, Nikos ![]() in Wiering, Marco; van Otterlo, Martijn (Eds.) Reinforcement Learning: State of the Art (2012) This chapter surveys recent lines of work that use Bayesian techniques for reinforcement learning. In Bayesian learning, uncertainty is expressed by a prior distribution over unknown parameters and ... [more ▼] This chapter surveys recent lines of work that use Bayesian techniques for reinforcement learning. In Bayesian learning, uncertainty is expressed by a prior distribution over unknown parameters and learning is achieved by computing a posterior distribution based on the data observed. Hence, Bayesian reinforcement learning distinguishes itself from other forms of reinforcement learning by explic- itly maintaining a distribution over various quantities such as the parameters of the model, the value function, the policy or its gradient. This yields several benefits: a) domain knowledge can be naturally encoded in the prior distribution to speed up learning; b) the exploration/exploitation tradeoff can be naturally optimized; and c) notions of risk can be naturally taken into account to obtain robust policies. [less ▲] Detailed reference viewed: 185 (8 UL)![]() Lehnert, Thorsten ![]() E-print/Working paper (2012) Detailed reference viewed: 25 (0 UL)![]() ; ; et al in The European journal of neuroscience (2012), 35(6), 896-908 Pathological synchronization in large-scale motor networks constitutes a pathophysiological hallmark of Parkinson's disease (PD). Corticomuscular synchronization in PD is pronounced in lower frequency ... [more ▼] Pathological synchronization in large-scale motor networks constitutes a pathophysiological hallmark of Parkinson's disease (PD). Corticomuscular synchronization in PD is pronounced in lower frequency bands (< 10 Hz), whereas efficient cortical motor integration in healthy persons is driven in the beta frequency range. Electroencephalogram and electromyogram recordings at rest and during an isometric precision grip task were performed in four perioperative sessions in 10 patients with PD undergoing subthalamic nucleus deep-brain stimulation: (i) 1 day before (D0); (ii) 1 day after (D1); (iii) 8 days after implantation of macroelectrodes with stimulation off (D8StimOff); and (iv) on (D8StimOn). Analyses of coherence and phase delays were performed in order to challenge the effects of microlesion and stimulation on corticomuscular coherence (CMC). Additionally, local field potentials recorded from the subthalamic nucleus on D1 allowed comprehensive mapping of motor-related synchronization in subthalamocortical and cerebromuscular networks. Motor performance improved at D8StimOn compared with D0 and D8StimOff paralleled by a reduction of muscular activity and CMC in the theta band (3.9-7.8 Hz) and by an increase of CMC in the low-beta band (13.7-19.5 Hz). Efferent motor cortical drives to muscle presented mainly below 10 Hz on D8StimOff that were suppressed on D8StimOn and occurred on higher frequencies from 13 to 45 Hz. On D1, coherence of the high-beta band (20.5-30.2 Hz) increased during movement compared with rest in subthalamomuscular and corticomuscular projections, whereas it was attenuated in subcorticocortical projections. The present findings lend further support to the concept of pathological network synchronization in PD that is beneficially modulated by stimulation. [less ▲] Detailed reference viewed: 124 (0 UL)![]() ; ; Nienaber, Birte ![]() in Naturschutz und Landschaftsplanung (2012), 44(11), 333-340 Biosphere reserves are considered as model regions for a sustainable development in which the relations between humans and the environment represent the focal point of research. However, only a few ... [more ▼] Biosphere reserves are considered as model regions for a sustainable development in which the relations between humans and the environment represent the focal point of research. However, only a few studies dealing with socio-economic questions have been carried out so far. Using the example of the still young Bliesgau biosphere reserve in Saarland, Germany, this contribution gives a first summary of its evaluation by the local population and first successes of the regional economy. The results of a quantitative survey provide information about the population’s awareness of institutions and offers, the disposition to actively participate and the perception of the Bliesgau biosphere reserve. Moreover, factors, which influence these aspects, are emphasized. By examining the regional economy, strengths and deficits, which inform about the regional added value, are pointed out additionally. The enforcement of regional economic cycles represents an important task in the Bliesgau biosphere reserve. Based on these results, our socio-economic studies provide the first basic principles and findings for future research as early as two years after the designation by UNESCO. [less ▲] Detailed reference viewed: 196 (7 UL)![]() Grammatikos, Theoharry ![]() ![]() E-print/Working paper (2012) Detailed reference viewed: 140 (0 UL)![]() Jullien, Eva ![]() in Hemecht : Zeitschrift für Luxemburger Geschichte = Revue d'Histoire Luxembourgeoise (2012), 64(4), 13-21 Detailed reference viewed: 173 (15 UL)![]() Glock, Sabine ![]() ![]() ![]() in International Journal of Technology and Inclusive Education (2012), 1 Detailed reference viewed: 152 (5 UL)![]() Bianculli, Domenico ![]() in Proceedings of the 34th International Conference on Software Engineering (ICSE 2012) (2012) Detailed reference viewed: 121 (7 UL)![]() Kolodkin, Alexey ![]() in European Journal of Pharmaceutical Sciences (2012), 46(4), 190-197 The development of disease may be characterized as a pathological shift of homeostasis; the main goal of contemporary drug treatment is, therefore, to return the pathological homeostasis back to the ... [more ▼] The development of disease may be characterized as a pathological shift of homeostasis; the main goal of contemporary drug treatment is, therefore, to return the pathological homeostasis back to the normal physiological range. From the view point of systems biology, homeostasis emerges from the interactions within the network of biomolecules (e.g. DNA, mRNA, proteins), and, hence, understanding how drugs impact upon the entire network should improve their efficacy at returning the network (body) to physiological homeostasis. Large, mechanism-based computer models, such as the anticipated human whole body models (silicon or virtual human), may help in the development of such network-targeting drugs. Using the philosophical concept of weak and strong emergence, we shall here take a more general look at the paradigm of network-targeting drugs, and propose our approaches to scale the strength of strong emergence. We apply these approaches to several biological examples and demonstrate their utility to reveal principles of bio-modeling. We discuss this in the perspective of building the silicon human. [less ▲] Detailed reference viewed: 142 (8 UL)![]() Milmeister, Marianne ![]() Report (2012) Detailed reference viewed: 96 (13 UL)![]() ![]() Vlassis, Nikos ![]() Scientific Conference (2012) It was recently shown that computing an optimal stochastic controller in a discounted in finite-horizon partially observable Markov decision process is an NP-hard problem. The reduction (from the ... [more ▼] It was recently shown that computing an optimal stochastic controller in a discounted in finite-horizon partially observable Markov decision process is an NP-hard problem. The reduction (from the independent-set problem) involves designing an MDP with special state-action rewards. In this note, we show that the case of state-only-dependent rewards is also NP-hard. [less ▲] Detailed reference viewed: 81 (14 UL)![]() Antony, Paul ![]() ![]() ![]() in Current Opinion in Biotechnology (2012), 23(4), 604-8 Systems Biology is about combining theory, technology, and targeted experiments in a way that drives not only data accumulation but knowledge as well. The challenge in Systems Biomedicine is to ... [more ▼] Systems Biology is about combining theory, technology, and targeted experiments in a way that drives not only data accumulation but knowledge as well. The challenge in Systems Biomedicine is to furthermore translate mechanistic insights in biological systems to clinical application, with the central aim of improving patients’ quality of life. The challenge is to find theoretically well-chosen models for the contextually correct and intelligible representation of multiscale biological systems. In this review, we discuss the current state of Systems Biology, highlight the emergence of Systems Biomedicine, and highlight some of the topics and views that we think are important for the efficient application of Systems Theory in Biomedicine. [less ▲] Detailed reference viewed: 207 (18 UL)![]() Glesener, Jeanne ![]() in Grucza, Franciszek; Neuberg, Simon; Conter, Claude D. (Eds.) et al Jiddische Spache und Literatur / Luxemburgistik / Niederländische Sprach- und Literaturwissenschaft mit besonderer Berücksichtigung des Afrikaans (2012) Detailed reference viewed: 126 (6 UL)![]() ; ; et al in The New England journal of medicine (2012), 366(1), 9-19 BACKGROUND: Acute coronary syndromes arise from coronary atherosclerosis with superimposed thrombosis. Since factor Xa plays a central role in thrombosis, the inhibition of factor Xa with low-dose ... [more ▼] BACKGROUND: Acute coronary syndromes arise from coronary atherosclerosis with superimposed thrombosis. Since factor Xa plays a central role in thrombosis, the inhibition of factor Xa with low-dose rivaroxaban might improve cardiovascular outcomes in patients with a recent acute coronary syndrome. METHODS: In this double-blind, placebo-controlled trial, we randomly assigned 15,526 patients with a recent acute coronary syndrome to receive twice-daily doses of either 2.5 mg or 5 mg of rivaroxaban or placebo for a mean of 13 months and up to 31 months. The primary efficacy end point was a composite of death from cardiovascular causes, myocardial infarction, or stroke. RESULTS: Rivaroxaban significantly reduced the primary efficacy end point, as compared with placebo, with respective rates of 8.9% and 10.7% (hazard ratio in the rivaroxaban group, 0.84; 95% confidence interval [CI], 0.74 to 0.96; P=0.008), with significant improvement for both the twice-daily 2.5-mg dose (9.1% vs. 10.7%, P=0.02) and the twice-daily 5-mg dose (8.8% vs. 10.7%, P=0.03). The twice-daily 2.5-mg dose of rivaroxaban reduced the rates of death from cardiovascular causes (2.7% vs. 4.1%, P=0.002) and from any cause (2.9% vs. 4.5%, P=0.002), a survival benefit that was not seen with the twice-daily 5-mg dose. As compared with placebo, rivaroxaban increased the rates of major bleeding not related to coronary-artery bypass grafting (2.1% vs. 0.6%, P<0.001) and intracranial hemorrhage (0.6% vs. 0.2%, P=0.009), without a significant increase in fatal bleeding (0.3% vs. 0.2%, P=0.66) or other adverse events. The twice-daily 2.5-mg dose resulted in fewer fatal bleeding events than the twice-daily 5-mg dose (0.1% vs. 0.4%, P=0.04). CONCLUSIONS: In patients with a recent acute coronary syndrome, rivaroxaban reduced the risk of the composite end point of death from cardiovascular causes, myocardial infarction, or stroke. Rivaroxaban increased the risk of major bleeding and intracranial hemorrhage but not the risk of fatal bleeding. (Funded by Johnson & Johnson and Bayer Healthcare; ATLAS ACS 2-TIMI 51 ClinicalTrials.gov number, NCT00809965.). [less ▲] Detailed reference viewed: 151 (0 UL)![]() Martin, Romain ![]() ![]() Book published by University of Luxembourg, EMACS (2012) Detailed reference viewed: 104 (12 UL)![]() ; ; et al Book published by Fac. Sci. Technol. Commun. Univ. Luxemb., Luxembourg (2012) Detailed reference viewed: 112 (12 UL)![]() Venken, Machteld ![]() Presentation (2012) Detailed reference viewed: 15 (0 UL)![]() ; ; et al in Journal of neurology (2012), 259(9), 1970-2 Detailed reference viewed: 143 (0 UL)![]() ![]() Poncelet, Débora ![]() Scientific Conference (2012) Detailed reference viewed: 48 (4 UL) |
||